Akebia Therapeutics (AKBA) director receives RSU and stock option grants
Rhea-AI Filing Summary
Akebia Therapeutics director Leanne M. Zumwalt received equity awards in the form of common stock and stock options. She was granted 35,700 shares of Common Stock as restricted stock units under Akebia’s 2023 Stock Incentive Plan, bringing her direct common stock holdings to 145,100 shares after the grant.
She was also granted a stock option for 53,600 shares of common stock with an exercise price of $1.02 per share, expiring on June 17, 2036. Both the RSUs and the option vest 100% on the first anniversary of the grant date, or earlier immediately before the first annual meeting of stockholders after the grant, if she continues serving the company.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 35,700 shares
Net Buy
2 txns
Insider
ZUMWALT LEANNE M
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to buy) | 53,600 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 35,700 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to buy) — 53,600 shares (Direct);
Common Stock — 145,100 shares (Direct)
Footnotes (2)
- F1. The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date.
- F2. The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continuous service to the Issuer through such vesting date.
Key Figures
RSU grant: 35,700 shares
Option grant size: 53,600 shares
Option exercise price: $1.02 per share
+3 more
6 metrics
RSU grant
35,700 shares
Restricted stock units granted June 17, 2026
Option grant size
53,600 shares
Stock option covering common stock granted June 17, 2026
Option exercise price
$1.02 per share
Conversion or exercise price of stock option
Option expiration
June 17, 2036
Expiration date of stock option grant
Shares owned after grant
145,100 shares
Total common stock directly held following RSU grant
RSU vesting schedule
100% after one year
Vests on first anniversary or before next annual meeting
Key Terms
restricted stock units, 2023 Stock Incentive Plan, Non-Employee Director Compensation Program, Stock Option
4 terms
restricted stock units financial
"The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2023 Stock Incentive Plan financial
"were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan")"
Non-Employee Director Compensation Program financial
"as provided by the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Program (the "Program")"
Stock Option financial
"The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity awards did Akebia (AKBA) director Leanne Zumwalt receive?
Leanne Zumwalt received 35,700 restricted stock units and a stock option covering 53,600 shares of Akebia common stock. Both awards were granted under the 2023 Stock Incentive Plan as part of the company’s non-employee director compensation program.
When do Leanne Zumwalt’s new Akebia RSUs and options vest?
Both the 35,700 restricted stock units and the 53,600-share stock option vest 100% on the first anniversary of the June 17, 2026 grant date. Vesting may occur earlier, immediately before the first annual stockholder meeting after grant, if she continues serving Akebia.
What is the exercise price and term of Leanne Zumwalt’s AKBA stock option?
The new stock option granted to Leanne Zumwalt allows purchase of 53,600 Akebia common shares at an exercise price of $1.02 per share. The option expires on June 17, 2036, assuming it vests and remains outstanding under the plan’s terms.
Are Leanne Zumwalt’s recent AKBA transactions open-market purchases?
No, the reported acquisitions are equity grants, not open-market purchases. She received 35,700 restricted stock units and a 53,600-share stock option at no purchase price, granted under Akebia’s 2023 Stock Incentive Plan for non-employee directors.